Red Rice Bran Extract Alleviates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease and Dyslipidemia in Mice
Nutrients · 2023-01-03 · 15 (1) · 246
DOI: 10.3390/nu15010246 ↗At a glance
Journal article in Nutrients, published online on 2023-01-03. Written by Narongsuk Munkong and 6 co-authors. Institution: Department of Pathology, School of Medicine, University of Phayao, Phayao 56000, Thailand. Major MEDLINE topics: Non-alcoholic Fatty Liver Disease, Oryza, Dyslipidemias. Cited 24 times so far (Crossref); 47 references. The full text is freely available (open access, CC BY 4.0). Funded by: Thailand Science Research and Innovation Fund, University of Phayao, Thailand, Research Group in Exercise and Aging-Associated Diseases, Faculty of Medicine, Thammasat University, Thailand.
Abstract (original language)
Red rice bran extract (RRBE) is rich in phytonutrients and has been shown to have anti-diabetic, anti-inflammatory, and antioxidant properties. However, its anti-hepatic steatosis and anti-dyslipidemic properties have not been thoroughly investigated. This study examined the aforementioned properties of RRBE, the underlying mechanism by which it alleviated non-alcoholic fatty liver disease in high-fat diet (HFD)-fed mice, and its major bioactive constituents. The mice were divided into four groups based on their diet: (1) low-fat diet (LFD), (2) LFD with high-dose RRBE (1 g/kg/day), (3) HFD, and (4) HFD with three different doses of RRBE (0.25, 0.5, and 1 g/kg/day). The administration of RRBE, especially at medium and high doses, significantly mitigated HFD-induced hepatosteatosis and concomitantly improved the serum lipid profile. Further, RRBE modified the level of expression of lipid metabolism-related genes (adipose triglyceride lipase (ATGL), cluster of differentiation 36 (CD36), lipoprotein lipase (LPL), liver X receptor alpha (LXRα), sterol regulatory element-binding protein-1c (SREBP-1c), SREBP-2, 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), and carnitine palmitoyltransferase 1A (CPT1A)) in hepatic or adipose tissues and improved the expression of hepatic high-density lipoprotein cholesterol (HDL-C) cmetabolism-related genes (hepatic lipase (HL) and apolipoprotein A-ǀ (ApoA-ǀ)). RRBE also attenuated markers of liver injury, inflammation, and oxidative stress, accompanied by a modulated expression of inflammatory (nuclear factor-kappa B (NF-κB) and inducible nitric oxide synthase (iNOS)), pro-oxidant (p47phox), and apoptotic (B-cell lymphoma protein 2 (Bcl-2)-associated X and Bcl-2) genes in the liver. High-performance liquid chromatography analyses indicated the presence of protocatechuic acid, γ-oryzanol, vitamin E, and coenzyme Q10 in RRBE. Our data indicate that RRBE alleviates HFD-induced hepatosteatosis, dyslipidemia, and their pathologic complications in part by regulating the expression of key genes involved in lipid metabolism, inflammation, oxidative stress, and apoptosis.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pathology, School of Medicine, University of Phayao, Phayao 56000, Thailand.
- Division of Nutrition for Health and Sport, Department of Sport and Health Sciences, Faculty of Sport Science, Kasetsart University, Nakhon Pathom 73140, Thailand.
- Applied Thai Traditional Medicine Program, School of Public Health, University of Phayao, Phayao 56000, Thailand.
- Division of Biochemistry, School of Medical Sciences, University of Phayao, Phayao 56000, Thailand.
- Agriculture Program, School of Agriculture and Natural Resources, University of Phayao, Phayao 56000, Thailand.
- Division of Physiology, Department of Preclinical Science, Faculty of Medicine, Thammasat University, Pathum Thani 12120, Thailand.
ORCID profiles: Narongsuk Munkong, Nattanida Jantarach, Bhornprom Yoysungnoen
Funding
- Thailand Science Research and Innovation Fund
- University of Phayao, Thailand
- Research Group in Exercise and Aging-Associated Diseases, Faculty of Medicine, Thammasat University, Thailand
Cite
APA
Munkong, N., Somnuk, S., Jantarach, N., Ruxsanawet, K., Nuntaboon, P., Kanjoo, V., & Yoysungnoen, B. (2023). Red Rice Bran Extract Alleviates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease and Dyslipidemia in Mice. Nutrients, 15(1), 246. https://doi.org/10.3390/nu15010246
Vancouver
Munkong N, Somnuk S, Jantarach N, Ruxsanawet K, Nuntaboon P, Kanjoo V, et al. Red Rice Bran Extract Alleviates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease and Dyslipidemia in Mice. Nutrients. 2023;15(1):246. doi:10.3390/nu15010246
BibTeX
@article{Munkong2023,
author = {Munkong, Narongsuk and Somnuk, Surasawadee and Jantarach, Nattanida and Ruxsanawet, Kingkarnonk and Nuntaboon, Piyawan and Kanjoo, Vaiphot and Yoysungnoen, Bhornprom},
title = {Red Rice Bran Extract Alleviates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease and Dyslipidemia in Mice},
journal = {Nutrients},
year = {2023},
volume = {15},
number = {1},
pages = {246},
doi = {10.3390/nu15010246}
}
EUVIMED